Cigna Corp. (NYSE:CI) shares rose 3.4% during mid-day trading on Thursday . The stock traded as high as $137.88 and last traded at $137.69, with a volume of 2,373,162 shares. The stock had previously closed at $133.11.

CI has been the subject of several recent research reports. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $149.00 target price on shares of Cigna Corp. in a report on Friday, July 8th. Zacks Investment Research cut shares of Cigna Corp. from a “hold” rating to a “sell” rating in a report on Monday, April 11th. Leerink Swann reaffirmed an “outperform” rating and issued a $175.00 price objective on shares of Cigna Corp. in a report on Tuesday, May 10th. Stifel Nicolaus assumed coverage on shares of Cigna Corp. in a report on Tuesday, June 28th. They issued a “buy” rating and a $169.00 price objective for the company. Finally, Wolfe Research assumed coverage on shares of Cigna Corp. in a report on Tuesday, June 28th. They issued an “outperform” rating and a $172.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. Cigna Corp. presently has an average rating of “Buy” and an average target price of $165.20.

The firm has a market cap of $35.99 billion and a PE ratio of 17.54. The firm has a 50-day moving average price of $128.67 and a 200-day moving average price of $134.14.

Cigna Corp. (NYSE:CI) last issued its quarterly earnings results on Friday, May 6th. The company reported $2.32 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.16 by $0.16. The business had revenue of $9.90 billion for the quarter, compared to analyst estimates of $9.98 billion. During the same quarter in the prior year, the company earned $1.96 EPS. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. Equities research analysts anticipate that Cigna Corp. will post $9.29 EPS for the current fiscal year.

Other hedge funds have recently added to or reduced their stakes in the company. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in Cigna Corp. during the fourth quarter valued at approximately $2,239,000. OppenheimerFunds Inc. boosted its stake in Cigna Corp. by 4.8% in the fourth quarter. OppenheimerFunds Inc. now owns 350,664 shares of the company’s stock valued at $51,321,000 after buying an additional 16,074 shares during the period. Gamco Investors INC. ET AL boosted its stake in Cigna Corp. by 8.6% in the fourth quarter. Gamco Investors INC. ET AL now owns 15,800 shares of the company’s stock valued at $2,312,000 after buying an additional 1,250 shares during the period. Brown Advisory Inc. boosted its stake in Cigna Corp. by 106.0% in the fourth quarter. Brown Advisory Inc. now owns 11,854 shares of the company’s stock valued at $1,734,000 after buying an additional 6,099 shares during the period. Finally, South Dakota Investment Council boosted its stake in Cigna Corp. by 6.9% in the fourth quarter. South Dakota Investment Council now owns 31,000 shares of the company’s stock valued at $4,536,000 after buying an additional 2,000 shares during the period.

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, Other Operations and Corporate.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.